TRADE BRIEF: COO — Cooper Companies

SETUP

COO broke above $61.30 resistance on 1.72x average volume, closing near the high of the bar at $61.65 after a 4.54% gap-up session. The move reclaims meaningful ground from a beaten-down position well off the 52-week high of $89.83. The risk/reward is modest at 1:1.54 with a tight stop at $60.17, giving roughly $1.47 of risk against $4.26 to TP2. The signal score of 50/100 flags that this entry is not early — the gap-up nature of the move means some of the easy money is already gone.

CATALYSTS

COO has beaten earnings estimates in five consecutive quarters, most recently $0.96 vs $0.93 on May 29. Consistent execution in contact lens and surgical segments supports steady revenue visibility. Medical devices in ophthalmology and fertility carry defensive characteristics in a risk-off environment. Beta of 0.825 limits drawdown sensitivity to broad market swings. Insider activity is notably bullish — multiple directors purchased shares in September 2026 totaling over 34,000 shares and roughly $1.88M in open-market buys, a strong directional signal from those closest to the business.

RISKS

The stock remains 31% below its 52-week high, meaning significant overhead supply exists and rallies can stall quickly on seller absorption. No analyst rating is provided, limiting external validation. Next earnings are not until September 2026, so there is no near-term catalyst to sustain momentum. The gap-up entry increases the chance of a fill-back toward prior close if buying pressure fades intraday. A close back below $60.17 invalidates the setup and likely signals the move was short-lived.

CONVICTION: Medium

Consistent earnings beats and aggressive insider buying support the bull case, but the late entry after a gap-up, heavy overhead supply, and a middling signal score of 50 keep conviction from reaching high.